Offer - Urjas Oil for just ₹ 1
Emletra Junior is a prescription medicine that is available as a Tablet. Emletra Junior also has some secondary and off-label uses. These are listed below.
The correct dosage of Emletra Junior depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Emletra Junior include Headache. Besides the aforementioned side effects, there are other adverse effects of Emletra Junior as well, which are listed below. Such side effects of Emletra Junior normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Emletra Junior has a Moderate effect for pregnant women and Moderate effect on lactating mothers. In addition, Emletra Junior's effects on the liver, heart and kidney are discussed below in the Emletra Junior related warnings section.
Emletra Junior is contraindicated in people with pre-existing medical conditions like Liver Disease, Hemophilia as it can result in adverse effects. Other contraindications of Emletra Junior have been discussed in the sections ahead.
Drug interactions for Emletra Junior have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Emletra Junior is considered not safe while driving, and is not addictive.
Emletra Junior is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Is the use of Emletra Junior safe for pregnant women?
Emletra Junior may have some side effects during pregnancy. Pregnant women should discontinue the use of Emletra Junior, and talk to their doctor, if they notice any discomfort.
Is the use of Emletra Junior safe during breastfeeding?
Emletra Junior can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Emletra Junior on the Kidneys?
Emletra Junior does not damage the kidneys.
What is the effect of Emletra Junior on the Liver?
Emletra Junior is rarely harmful for the liver.
What is the effect of Emletra Junior on the Heart?
Emletra Junior has very mild side effects on the heart.
Emletra Junior should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Emletra Junior unless your doctor advises you to do so -
Is this Emletra Junior habit forming or addictive?
No, there is no any evidence that Emletra Junior is addictive.
Interaction between Food and Emletra Junior
Eating certain foods may increase the time it takes Emletra Junior to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Emletra Junior
Taking alcohol with Emletra Junior can be dangerous.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvir (ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 810
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 939-941
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Kaletra (lopinavir and ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 811
